Genzyme says Unsolicited Proposal, not right time to sell the company
By Frontier India Pharmacetuicals News | August 30th, 2010 | Category: Latest, Medical Company News | No Comments »Genzyme responding to Sanofi-aventis $18.5 billion All-Cash Offer says that “without exception, each member of the Genzyme board believes this is not the right time to sell the company, because your opportunistic takeover proposal does not begin to recognize the significant progress underway to rectify our manufacturing challenges or the potential for our new-product pipeline.” [...]
